This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holland, S. J. Articles by Lorens, J. B. Search for Related Content PubMed PubMed Citation Articles by Holland, S. J. Articles by Lorens, J. B.

Multiple Roles for the Receptor Tyrosine Kinase Axl in Tumor Formation

¹ Rigel, Inc., South San Francisco, California and ² University of Michigan School of Dentistry, Ann Arbor, Michigan

Requests for reprints: Sacha J. Holland, Rigel, Inc., 1180 Veteran's Boulevard, South San Francisco, CA 94080. Phone: 650-624-1283; E-mail: sholland{at}rigel.com.

A focus of contemporary cancer therapeutic development is the targeting of both the transformed cell and the supporting cellular microenvironment. Cell migration is a fundamental cellular behavior required for the complex interplay between multiple cell types necessary for tumor development. We therefore developed a novel retroviral-based screening technology in primary human endothelial cells to discover genes that control cell migration. We identified the receptor tyrosine kinase Axl as a novel regulator of endothelial cell haptotactic migration towards the matrix factor vitronectin. Using small interfering RNA–mediated silencing and overexpression of wild-type or mutated receptor proteins, we show that Axl is a key regulator of multiple angiogenic behaviors including endothelial cell migration, proliferation, and tube formation in vitro. Moreover, using sustained, retrovirally delivered short hairpin RNA (shRNA) Axl knockdown, we show that Axl is necessary for in vivo angiogenesis in a mouse model. Furthermore, we show that Axl is also required for human breast carcinoma cells to form a tumor in vivo. These findings indicate that Axl regulates processes vital for both neovascularization and tumorigenesis. Disruption of Axl signaling using a small-molecule inhibitor will hence simultaneously affect both the tumor and stromal cell compartments and thus represents a unique approach for cancer therapeutic development.

This article has been cited by other articles:

				Y.-X. Zhang, P. G. Knyazev, Y. V. Cheburkin, K. Sharma, Y. P. Knyazev, L. Orfi, I. Szabadkai, H. Daub, G. Keri, and A. Ullrich AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression Cancer Res., March 15, 2008; 68(6): 1905 - 1915. [Abstract] [Full Text] [PDF]

				M. Hutterer, P. Knyazev, A. Abate, M. Reschke, H. Maier, N. Stefanova, T. Knyazeva, V. Barbieri, M. Reindl, A. Muigg, et al. Axl and Growth Arrest Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme Clin. Cancer Res., January 1, 2008; 14(1): 130 - 138. [Abstract] [Full Text] [PDF]

				T. Revil, J. Toutant, L. Shkreta, D. Garneau, P. Cloutier, and B. Chabot Protein Kinase C-Dependent Control of Bcl-x Alternative Splicing Mol. Cell. Biol., December 15, 2007; 27(24): 8431 - 8441. [Abstract] [Full Text] [PDF]

				M. C. Abba, V. T. Fabris, Y. Hu, F. S. Kittrell, W.-W. Cai, L. A. Donehower, A. Sahin, D. Medina, and C. M. Aldaz Identification of Novel Amplification Gene Targets in Mouse and Human Breast Cancer at a Syntenic Cluster Mapping to Mouse ch8A1 and Human ch13q34 Cancer Res., May 1, 2007; 67(9): 4104 - 4112. [Abstract] [Full Text] [PDF]

				J.-D. Lay, C.-C. Hong, J.-S. Huang, Y.-Y. Yang, C.-Y. Pao, C.-H. Liu, Y.-P. Lai, G.-M. Lai, A.-L. Cheng, I.-J. Su, et al. Sulfasalazine Suppresses Drug Resistance and Invasiveness of Lung Adenocarcinoma Cells Expressing AXL Cancer Res., April 15, 2007; 67(8): 3878 - 3887. [Abstract] [Full Text] [PDF]

				G. D.M. Collett, A. P. Sage, J. P. Kirton, M. Y. Alexander, A. P. Gilmore, and A. E. Canfield Axl/Phosphatidylinositol 3-Kinase Signaling Inhibits Mineral Deposition by Vascular Smooth Muscle Cells Circ. Res., March 2, 2007; 100(4): 502 - 509. [Abstract] [Full Text] [PDF]

				T. Nakamura, I. J. Fidler, and K. R. Coombes Gene Expression Profile of Metastatic Human Pancreatic Cancer Cells Depends on the Organ Microenvironment Cancer Res., January 1, 2007; 67(1): 139 - 148. [Abstract] [Full Text] [PDF]

				P. Vajkoczy, P. Knyazev, A. Kunkel, H.-H. Capelle, S. Behrndt, H. von Tengg-Kobligk, F. Kiessling, U. Eichelsbacher, M. Essig, T.-A. Read, et al. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival PNAS, April 11, 2006; 103(15): 5799 - 5804. [Abstract] [Full Text] [PDF]

				Y. Jenkins, V. Markovtsov, W. Lang, P. Sharma, D. Pearsall, J. Warner, C. Franci, B. Huang, J. Huang, G. C. Yam, et al. Critical Role of the Ubiquitin Ligase Activity of UHRF1, a Nuclear RING Finger Protein, in Tumor Cell Growth Mol. Biol. Cell, December 1, 2005; 16(12): 5621 - 5629. [Abstract] [Full Text] [PDF]